Market Overview
ASX 200 Index
Time to Get Active on Super Collapses
$1.2B First Guardian/Shield super collapse hits 11,000 investors as deadlines loom; AFCA and Netwealth payouts underway - check if you’re affected
The Weekly Finger: Older, fitter, faster, more fragile
Markets shift as AI fuels software sector; old leadership fades while new contenders tighten their grip.
Health Insurance Costs Just Keep Rising
Australian private health insurance premiums rise 4.41% from April 1, the steepest since 2017, as cover downgrades rise and Medibank posts profits.
Silver’s Historic Rally and the Structural Deficit: Are ASX Small Caps Underappreciated?
Silver surges on structural deficit and tariff fears; ASX miners poised to benefit as supply tightens—are Australian small caps undervalued?
Boss Energy Reports $36.2m Positive Net Cash Flow from Honeymoon Uranium Project
Boss Energy (ASX: BOE) logs $36.2m positive net cash flow from Honeymoon uranium project; six months to Dec lift in uranium sales, lower C1 costs boost outlook.
Weekly Wrap: ASX slips on war fears as earnings beat expectations buoy week
War fears nudge ASX 200 lower despite QBE's 21% profit surge; energy gains lift oil names, tech slumps; Guzman sinks below float.
ANZ Soars and AMP Sinks: Earnings Breakdown
ANZ delivers $1.9b cash profit in Q1, 3bp NIM uplift, and cost discipline driving outperformance as Feb earnings season kicks off (AMP results due).
CBA Up 8%: Double Down on NAB or Add Small Caps PPM, JDO?
CBA jumps 8% to above $171, reigniting the Big Four debate as rivals rally; strong profit, higher dividend, and rich multiples raise the risk-reward for banks.
Boss Energy Reports $36.2m Positive Net Cash Flow from Honeymoon Uranium Project
Boss Energy (ASX: BOE) logs $36.2m positive net cash flow from Honeymoon uranium project; six months to Dec lift in uranium sales, lower C1 costs boost outlook.
Core Lithium Secures Key Funding Via Glencore Stockpile Sale Ahead of Restart Decision
Core Lithium (CXO) has secured a vital near-term funding boost by agreeing to sell a significant portion of its spodumene concentrate stockpile to Glencore for approximately US$2,023 per dmt CIF, prov
EcoGraf De-Risks Epanko Graphite Project with Updated BFS
EcoGraf updates Epanko BFS, de-risking Tanzania graphite; Stage 1 US$516m, 73,000 tpa, HFfree purification, Africa’s largest graphite resource.
Marmota Delivers Wide Bonanza-Grade Gold Intercepts at Greenewood Project
Marmota hits bonanza-grade gold at Greenewood: 44m @2.3 g/t incl. 4m @16 g/t; open along strike, RC program in March to expand discovery.
Control Bionics Signs US JV for iOS Speech Devices with NextLevel Assistive Technology
Control Bionics inks exclusive US JV with NextLevel for iOS speech devices, FDA Manufacturer of Record; aims 1,000–1,500 units/year in a USD 100–150m market.
Radiopharm Theranostics Doses First Patient in RV-01 Phase 1/2a Trial for Aggressive Cancers
RAD doses first patient in RV-01 Phase 1/2a trial for aggressive cancers, a 177Lu-radiotherapeutic targeting B7-H3, to define dose for future studies.
Lumos Diagnostics Achieves BARDA Paediatric Study Milestone, Secures US$720k Payment
Lumos Diagnostics hits BARDA Milestone 6, secures US$720k non-dilutive payment as FebriDx paediatric study advances toward FDA submission and wider US TAM.
Little Green Pharma to Divest WA Production Site in $7.8 Million Sale and Lease-Back Deal
LGP to sell WA production site for $7.8m in a sale-and-lease-back to fund Australian and European expansion; settlement targeted mid-March 2026.
ArchTIS Lands US/EU Military Alliance Contract for NC Protect, Secures A$8M Facility
ArchTIS wins US/EU military alliance contract for NC Protect; up to A$1.22m potential, plus A$8m banking facility to fund US expansion.
Comms Group Delivers Record 1H FY26 Result, Reiterates Guidance
Comms Group hits record 1H FY26: revenue $37.6m, EBITDA $4.5m; TasmaNet integration boosts growth; FY26 guidance reaffirmed.
Findi to Seek Shareholder Approval for $72m Strategic Investment by Nova Global Opportunities Fund
Findi to seek shareholder approval for up to $72m Nova Global investment to back India ATM rollout; initial $26m already arranged.
Spacetalk Executes Strategic MOU with Vodafone Australia for Family Safety Software
Spacetalk signs 12-month MOU with Vodafone Australia via TPG to distribute Family Safety software to postpaid customers, targeting $20-25m ARR by CY2026.
TMK Energy Surpasses Production Milestone at Gurvantes XXXV CSG Project
TMK Energy surpasses 25,000 scfd at Gurvantes XXXV CSG project, led by LF-07, with desorption signs hinting at near-term expansion and funding talks.
Bass Oil Awarded $3.5m SA Government Grant for Kiwi Gas Project
Bass Oil (ASX: BAS) awarded $3.5m SA government grant for Kiwi liquids-rich gas project; pipeline to Cooper Basin; online by end-2028.
Elixir Energy Delivers Outstanding Results at Lorelle-3, Unveiling Significant Gas-Condensate Reservoirs
Elixir Energy (ASX: EXR) reports Lorelle-3: four gas-condensate reservoirs, northward Dunk extension; boosting Taroom Trough maiden reserves; 2026 flow tests.
Prominence Energy Kicks Off Field Work in PEL 803 with Geochemical Survey for Natural Hydrogen
Prominence Energy (ASX: PRM) has initiated its first field exploration for natural hydrogen and helium with a geochemical survey in South Australia's PEL 803.
SciDev Navigates 1H FY26 Headwinds with Recurring Revenue Focus and Revised Guidance
SciDev 1H FY26: revenue down to $47.9m; pivots to recurring revenue, FY26 guidance raised to $100-$110m, with cost cuts and Rum Jungle upside.
Wiseway Group Posts Robust 1H26 Results with 20% Revenue Surge and Profit Growth
Wiseway Group posts 1H26: revenue up 20% to $100.3m, PBT jumps 78%, US expansion fuels growth; interim dividend up 50% to 0.6c.
Metal Powder Works Secures UK Ministry of Defence Order, Bolstering NATO Network Position
Metal Powder Works lands UK MOD order, entering NATO defence network with DirectPowder titanium, boosting US-based production node and defence momentum.
ClearView Wealth Receives $415m Takeover Bid from Zurich Insurance Group
ClearView Wealth (CVW) faces a $415m takeover bid from Zurich; cash $0.65/share (~20% vs 3m VWAP, ~26% vs 12m VWAP) — board unanimously backs the scheme.
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]
Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]
ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]